mhurhangee/ep-ind-claims huggingface dataset:
Method for the selection or the processing of first particles (CELL) sensitive to the application of an external stimulus comprising the step of obtaining, through the application of said external stimulus, the permeabilization of at least a selected first particle (CELL), characterized in that it comprises the steps of: a) selectively energizing electrodes of an array of selectable electrodes having dimensions comparable with or lower than those of said first particles (CELL), as to apply to all of said electrodes a first pattern of voltages to generate a first force field (FMAN), by means of which said first particles (CELL) are organized bringing said first particles (CELL) towards first points of stable equilibrium (MPEQ) situated in proximity of said electrodes; b) applying to all and the same said selectable electrodes a second pattern of voltages different from the first pattern, so as to provide between at least two selected electrodes of said array adjacent to each other and positioned in proximity of the at least one selected first particle to be permeabilized (CELL) a second force field (FZAP), and such as to produce the application to said at least one selected first particle (CELL) of a stimulus suitable for bringing said at least one first selected particle (CELL) in a permeabilized state for at least a fraction of the length of said stimulus. a) selectively energizing electrodes of an array of selectable electrodes having dimensions comparable with or lower than those of said first particles (CELL), as to apply to all of said electrodes a first pattern of voltages to generate a first force field (FMAN), by means of which said first particles (CELL) are organized bringing said first particles (CELL) towards first points of stable equilibrium (MPEQ) situated in proximity of said electrodes; b) applying to all and the same said selectable electrodes a second pattern of voltages different from the first pattern, so as to provide between at least two selected electrodes of said array adjacent to each other and positioned in proximity of the at least one selected first particle to be permeabilized (CELL) a second force field (FZAP), and such as to produce the application to said at least one selected first particle (CELL) of a stimulus suitable for bringing said at least one first selected particle (CELL) in a permeabilized state for at least a fraction of the length of said stimulus.
An inverter having a structure that a first p-channel MOS transistor (3T1) and a first n-channel MOS transistor (3T2) are connected in this order in series with respect to the line of a source or drain and from a node adapted to be connected to a side of a first power supply providing a power, to a node connected to a side of a second power supply providing a ground voltage, a gate of said first p-channel MOS transistor and a gate of said first n-channel MOS transistor are connected to each other to define an input, and a node between said first p-channel MOS transistor and said first n-channel MOS transistor defines an output, characterized in that: said first p-channel MOS transistor (3T1) constitutes a dual structure by being connected with a second p-channel MOS transistor (3T3) in series with respect to the line of a source or drain at a node of said first p-channel MOS transistor (3T1) on a side of the second power supply, and their gates being connected to each other, and said first n-channel MOS transistor (3T2) constitutes a dual structure by being connected with a third p-channel MOS transistor (3T4) in series with respect to the line of a source or drain at the node on the side of the first power supply, and the gate of the third p-channel MOS transistor (3T4) being connected in common to the node of said first n-channel MOS transistor (3T2) on the side of the first power supply and the node of said first p-channel MOS transistor (3T1) on the side of the second power supply; the gates of the first p-channel MOS transistor (3T1) and the second p-channel transistor (3T3) are spaced apart by a predetermined space, and the gates of the first n-channel transistor (3T2) and the second n-channel transistor (3T4) are spaced apart by a predetermined space. said first p-channel MOS transistor (3T1) constitutes a dual structure by being connected with a second p-channel MOS transistor (3T3) in series with respect to the line of a source or drain at a node of said first p-channel MOS transistor (3T1) on a side of the second power supply, and their gates being connected to each other, and said first n-channel MOS transistor (3T2) constitutes a dual structure by being connected with a third p-channel MOS transistor (3T4) in series with respect to the line of a source or drain at the node on the side of the first power supply, and the gate of the third p-channel MOS transistor (3T4) being connected in common to the node of said first n-channel MOS transistor (3T2) on the side of the first power supply and the node of said first p-channel MOS transistor (3T1) on the side of the second power supply; the gates of the first p-channel MOS transistor (3T1) and the second p-channel transistor (3T3) are spaced apart by a predetermined space, and the gates of the first n-channel transistor (3T2) and the second n-channel transistor (3T4) are spaced apart by a predetermined space.
A computer-implemented method for adjusting one or more images of a sample to correct geometric distortions and/or align the one or more images, the method comprising: obtaining one or more images of a sample using one or more cameras at one or more fixed positions with respect to the sample; obtaining one or more images of a two-dimensional graphical pattern using the same one or more cameras in the same one or more fixed positions that were used or that will be used to obtain the one or more images of the sample, wherein the graphical pattern is a lattice comprising dots at vertices that define one or more types of geometric shapes, wherein the lattice of dots is non-periodic, and wherein absolute positions of the imaged dots can be determined; and automatically adjusting, by a processor of a computing device, the one or more images of the sample using the one or more images of the two-dimensional graphical pattern to correct geometric distortions and/or to align the one or more images of the sample. obtaining one or more images of a sample using one or more cameras at one or more fixed positions with respect to the sample; obtaining one or more images of a two-dimensional graphical pattern using the same one or more cameras in the same one or more fixed positions that were used or that will be used to obtain the one or more images of the sample, wherein the graphical pattern is a lattice comprising dots at vertices that define one or more types of geometric shapes, wherein the lattice of dots is non-periodic, and wherein absolute positions of the imaged dots can be determined; and wherein the graphical pattern is a lattice comprising dots at vertices that define one or more types of geometric shapes, wherein the lattice of dots is non-periodic, and wherein absolute positions of the imaged dots can be determined; and automatically adjusting, by a processor of a computing device, the one or more images of the sample using the one or more images of the two-dimensional graphical pattern to correct geometric distortions and/or to align the one or more images of the sample.
A cell comprising (a) a first vector comprising an integrase-defective lentiviral (IDLV) donor polynucleotide comprising, between the lentivirus LTRs, (i) first and second nucleotide sequences that are homologous sequences to a region of interest of cellular chromatin of the cell; and (ii) an exogenous sequence; and (b) a second vector comprising a polynucleotide encoding a zinc finger nuclease that stimulates integration of the exogenous sequence into the region of interest, wherein the second vector is a plasmid vector, a retroviral vector, an adenoviral vector or an adeno-associated viral vector. (a) a first vector comprising an integrase-defective lentiviral (IDLV) donor polynucleotide comprising, between the lentivirus LTRs, (i) first and second nucleotide sequences that are homologous sequences to a region of interest of cellular chromatin of the cell; and (ii) an exogenous sequence; and (i) first and second nucleotide sequences that are homologous sequences to a region of interest of cellular chromatin of the cell; and (ii) an exogenous sequence; and (b) a second vector comprising a polynucleotide encoding a zinc finger nuclease that stimulates integration of the exogenous sequence into the region of interest, wherein the second vector is a plasmid vector, a retroviral vector, an adenoviral vector or an adeno-associated viral vector.
Composition comprising urea derivatives of formula wherein R2, R3, R4 independently of one another denote - hydrogen or - linear or branched C1-C10-alkyl, which is optionally substituted with substituted or unsubstituted cyclic C5-C10- alkyl or - cyclic C5-C10- alkyl, which is optionally substituted with hydroxy or C1-C4-alkyl, and R5 denotes hydrogen, hydroxyl or C1-C4-alkyl, for therapeutic use to protect stem cells against UVB irradiation. R2, R3, R4 independently of one another denote - hydrogen or - linear or branched C1-C10-alkyl, which is optionally substituted with substituted or unsubstituted cyclic C5-C10- alkyl or - cyclic C5-C10- alkyl, which is optionally substituted with hydroxy or C1-C4-alkyl, and R5 denotes hydrogen, hydroxyl or C1-C4-alkyl, - hydrogen or - linear or branched C1-C10-alkyl, which is optionally substituted with substituted or unsubstituted cyclic C5-C10- alkyl or - cyclic C5-C10- alkyl, which is optionally substituted with hydroxy or C1-C4-alkyl, and R5 denotes hydrogen, hydroxyl or C1-C4-alkyl,
A method of controlling the acid balance in a high chloride heap leach process, carried out at ambient temperature, wherein the chloride concentration is between 100g/L and 180g/L to ensure that the copper dissolution in the agglomeration stage is not limited by acid to maximise the copper dissolution in the cure step and thereby increase the overall copper recovery wherein the method includes the following: a. an agglomeration stage in which acid and process solutions are combined with the ore prior to stacking to form a heap; b. an aerated, but non-irrigated, cure phase to leach a portion of the copper in the ore in the heap wherein copper dissolution in the cure phase is at least 30%; and c. an irrigated leach phase during which the remaining copper minerals are leached and copper is recovered from a pregnant leach solution by a solvent extraction step followed by an electrowinning step, and wherein the heap comprises a plurality of heap sections in which excess acid in the irrigated leach phase is reduced by circulating leach liquor to the heap sections counter-current to the ore loading onto the heap sections and removal of the ore from the heap sections, thereby increasing acid consumption by gangue mineral dissolution in proportion to the number of heap sections irrigated and the acid concentration in the pregnant leach solution, which reports to the solvent extraction step, is less than 10 g/L, to allow effective copper recovery from the pregnant leach solution in the solvent extraction step. a. an agglomeration stage in which acid and process solutions are combined with the ore prior to stacking to form a heap; b. an aerated, but non-irrigated, cure phase to leach a portion of the copper in the ore in the heap wherein copper dissolution in the cure phase is at least 30%; and c. an irrigated leach phase during which the remaining copper minerals are leached and copper is recovered from a pregnant leach solution by a solvent extraction step followed by an electrowinning step, and wherein
An ambulatory medical device (110; 200), comprising: a signal receiver circuit, configured to receive a physiologic signal, for detecting a physiologic target event or condition of a patient; a confounding event detector circuit, including a confounding event-bearing signal receiver circuit configured to receive at least one CEB signal, the confounding event detector configured to determine presence of a confounding event, different from the target event or condition, from the at least one CEB signal; a signal processing circuit, configured to segment the physiologic signal into at least first and second segments, and adjust at least one of the first or second segments to remove or lessen the impact of a confounding event on the physiological signal; and a target event or condition detector circuit, configured to detect the target event or condition from the at least one of the first or second adjusted segments of the physiologic signal, wherein the confounding event detector circuit is configured to determine the presence of the confounding event using whether the at least one CEB signal meets at least one physiologically relevant criterion, wherein the at least one physiologically relevant criterion includes pre-determined threshold values for signal features, wherein, if the values of one or more CEB signal features are outside the range of physiological relevancy, then a confounding event is deemed detected and, if the values of the one or more CEB signal features are within the range of physiological relevancy, then no confounding event is deemed detected. a signal receiver circuit, configured to receive a physiologic signal, for detecting a physiologic target event or condition of a patient; a confounding event detector circuit, including a confounding event-bearing signal receiver circuit configured to receive at least one CEB signal, the confounding event detector configured to determine presence of a confounding event, different from the target event or condition, from the at least one CEB signal; a signal processing circuit, configured to segment the physiologic signal into at least first and second segments, and adjust at least one of the first or second segments to remove or lessen the impact of a confounding event on the physiological signal; and a target event or condition detector circuit, configured to detect the target event or condition from the at least one of the first or second adjusted segments of the physiologic signal, wherein the confounding event detector circuit is configured to determine the presence of the confounding event using whether the at least one CEB signal meets at least one physiologically relevant criterion, wherein the at least one physiologically relevant criterion includes pre-determined threshold values for signal features, wherein, if the values of one or more CEB signal features are outside the range of physiological relevancy, then a confounding event is deemed detected and, if the values of the one or more CEB signal features are within the range of physiological relevancy, then no confounding event is deemed detected.
A policy control method, comprising: receiving, by a gateway device, network address translation, NAT, entry information sent by a NAT device; receiving, by the gateway device, a first policy and charging control, PCC, rule sent by a policy and charging rules function, PCRF, entity, wherein the first PCC rule is a PCC rule comprising an IPv4 address of a user equipment, UE, obtained through translating by the NAT device; translating, by the gateway device, the first PCC rule into a second PCC rule according to the NAT entry information, wherein the second PCC rule is a PCC rule comprising an IPv6 address of the UE to be translated by the NAT device; and executing, by the gateway device, the second PCC rule; wherein the gateway is a Gateway GPRS Supporting Node, GGSN, a Packet Data Network Gateway, PGW, or an Evolved Packet Data Gateway, ePDG. receiving, by a gateway device, network address translation, NAT, entry information sent by a NAT device; receiving, by the gateway device, a first policy and charging control, PCC, rule sent by a policy and charging rules function, PCRF, entity, wherein the first PCC rule is a PCC rule comprising an IPv4 address of a user equipment, UE, obtained through translating by the NAT device; translating, by the gateway device, the first PCC rule into a second PCC rule according to the NAT entry information, wherein the second PCC rule is a PCC rule comprising an IPv6 address of the UE to be translated by the NAT device; and executing, by the gateway device, the second PCC rule; wherein the gateway is a Gateway GPRS Supporting Node, GGSN, a Packet Data Network Gateway, PGW, or an Evolved Packet Data Gateway, ePDG.
A speech/audio signal processing method, comprising: if a first wideband speech/audio signal is a harmonic signal, adjusting a determining condition for determining that a second wideband speech/audio signal is a harmonic signal, to obtain a first determining condition, so as to raise a possibility of determining that the second wideband speech/audio signal is a harmonic signal, wherein the first wideband speech/audio signal is a speech/audio signal before wideband switching, and the second wideband speech/audio signal is a speech/audio signal after the wideband switching; wherein, the first wideband speech/audio signal is an ultra-wideband signal, and the second wideband speech/audio signal after the switching is a wideband signal; or the first wideband speech/audio signal is a wideband signal, and the second wideband speech/audio signal after the switching is an ultra-wideband signal; and determining, according to the first determining condition, whether the second wideband speech/audio signal is a harmonic signal. if a first wideband speech/audio signal is a harmonic signal, adjusting a determining condition for determining that a second wideband speech/audio signal is a harmonic signal, to obtain a first determining condition, so as to raise a possibility of determining that the second wideband speech/audio signal is a harmonic signal, wherein the first wideband speech/audio signal is a speech/audio signal before wideband switching, and the second wideband speech/audio signal is a speech/audio signal after the wideband switching; wherein, the first wideband speech/audio signal is an ultra-wideband signal, and the second wideband speech/audio signal after the switching is a wideband signal; or the first wideband speech/audio signal is a wideband signal, and the second wideband speech/audio signal after the switching is an ultra-wideband signal; and determining, according to the first determining condition, whether the second wideband speech/audio signal is a harmonic signal.
A method comprising: receiving, at a physical layer, PHY, circuitry of a receiver, a first bit sequence corresponding to a first ordered set of eight bytes, the first bit sequence received at a predetermined ordered set interval, the predetermined ordered set interval following a flow control unit, flit; receiving, at the physical layer circuitry, a second bit sequence corresponding to a second ordered set of eight bytes, the first bit sequence immediately adjacent to the second bit sequence, wherein both bit sequences are considered as good ordered set if both bit sequences are good, wherein each of the bit sequences has its own built-in redundancy, or are considered as good ordered set if either of both bit sequences is good, wherein each of the bit sequences is independently CRC protected; comparing a portion of the first bit sequence and the second bit sequence against expected values for the first and the second bit sequences; determining a presence or absence of bit errors from the first bit sequence and the second bit sequence based on the comparison; and determining a type of ordered set based on the comparison. receiving, at a physical layer, PHY, circuitry of a receiver, a first bit sequence corresponding to a first ordered set of eight bytes, the first bit sequence received at a predetermined ordered set interval, the predetermined ordered set interval following a flow control unit, flit; receiving, at the physical layer circuitry, a second bit sequence corresponding to a second ordered set of eight bytes, the first bit sequence immediately adjacent to the second bit sequence, wherein both bit sequences are considered as good ordered set if both bit sequences are good, wherein each of the bit sequences has its own built-in redundancy, or are considered as good ordered set if either of both bit sequences is good, wherein each of the bit sequences is independently CRC protected; comparing a portion of the first bit sequence and the second bit sequence against expected values for the first and the second bit sequences; determining a presence or absence of bit errors from the first bit sequence and the second bit sequence based on the comparison; and determining a type of ordered set based on the comparison.
A lighting device comprising: - a first solid state light source, configured to provide UV radiation having a wavelength selected from the range of 380-420 nm; - a second solid state light source, configured to provide blue light having a wavelength selected from the range of 440-470 nm; - a wavelength converter element, wherein the wavelength converter element comprises: - a first luminescent material, configured to provide upon excitation with the blue light of the second solid state light source first luminescent material light having a wavelength selected from the green and yellow wavelength range, and wherein the first luminescent material excitability for UV radiation is lower than for blue light; and - a second luminescent material, configured to provide upon excitation with the blue light of the second solid state light source second luminescent material light having a wavelength selected from the orange and red wavelength range, and wherein the second luminescent material excitability for UV radiation is lower than for blue light; wherein the lighting device is configured to provide lighting device light which comprises said UV radiation, said blue light, said first luminescent material light and said second luminescent material light. - a first solid state light source, configured to provide UV radiation having a wavelength selected from the range of 380-420 nm; - a second solid state light source, configured to provide blue light having a wavelength selected from the range of 440-470 nm; - a wavelength converter element, wherein the wavelength converter element comprises: - a first luminescent material, configured to provide upon excitation with the blue light of the second solid state light source first luminescent material light having a wavelength selected from the green and yellow wavelength range, and wherein the first luminescent material excitability for UV radiation is lower than for blue light; and - a second luminescent material, configured to provide upon excitation with the blue light of the second solid state light source second luminescent material light having a wavelength selected from the orange and red wavelength range, and wherein the second luminescent material excitability for UV radiation is lower than for blue light;
An indium phthalocyanine compound, which is 1,8,15,22 -tetra-(3,5-di-tert-butylphenoxy) indium phthalocyanine, with the following formula for use in the treatment of cervical cancer;